These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 9504687

  • 1. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV.
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [Abstract] [Full Text] [Related]

  • 2. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
    Erickson LA, Yousef OM, Jin L, Lohse CM, Pankratz VS, Lloyd RV.
    Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O.
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [Abstract] [Full Text] [Related]

  • 4. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S.
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
    Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK.
    J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories.
    Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML.
    Am J Surg Pathol; 1999 Jun; 23(6):678-85. PubMed ID: 10366150
    [Abstract] [Full Text] [Related]

  • 8. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 9. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G.
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [Abstract] [Full Text] [Related]

  • 10. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP, Lipman J, Goldman H, Ellis FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M, Loda M.
    Cancer Res; 1998 Apr 15; 58(8):1730-5. PubMed ID: 9563491
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S, Ogane N, Yasuda M, Muramatsu T, Bessho T, Kajiwara H, Osamura RY.
    Mod Pathol; 2000 Jul 15; 13(7):736-41. PubMed ID: 10912932
    [Abstract] [Full Text] [Related]

  • 12. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV.
    Mod Pathol; 2000 Feb 15; 13(2):186-92. PubMed ID: 10697277
    [Abstract] [Full Text] [Related]

  • 13. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S, Yang G, Harper JW, Lu X, Kattan MW, Thompson TC, Wheeler TM.
    Mod Pathol; 1999 Aug 15; 12(8):751-5. PubMed ID: 10463475
    [Abstract] [Full Text] [Related]

  • 14. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
    Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB.
    Cancer Res; 1998 Jan 01; 58(1):114-22. PubMed ID: 9426067
    [Abstract] [Full Text] [Related]

  • 15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 16. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
    Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A.
    Mod Pathol; 2000 Aug 01; 13(8):882-7. PubMed ID: 10955455
    [Abstract] [Full Text] [Related]

  • 17. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Sałacińska-Loś E, Kulig A, Włoch J.
    Pol J Pathol; 2004 Aug 01; 55(4):143-8. PubMed ID: 15757201
    [Abstract] [Full Text] [Related]

  • 18. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
    Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M.
    Cancer Res; 1997 Apr 01; 57(7):1259-63. PubMed ID: 9102210
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3403-11. PubMed ID: 17882495
    [Abstract] [Full Text] [Related]

  • 20. Role of Ki-67 as a proliferative marker in lesions of thyroid.
    Pujani M, Arora B, Pujani M, Singh SK, Tejwani N.
    Indian J Cancer; 2010 Dec 01; 47(3):304-7. PubMed ID: 20587907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.